The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.3, 2013-06, pp. : 371-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Non-Taxane-Containing Chemotherapy in Advanced Non-Small Cell Lung Cancer

By Bergqvist Michael

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 223-244

Adis International

Access to resources Recommend Favorite

A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens

By Kosmas Christos Tsavaris Nicolas Syrigos Konstantinos Koutras Angelos Tsakonas George Makatsoris Thomas Mylonakis Nicolas Karabelis Athanasios Stathopoulos George Kalofonos Haralambos

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 51-59

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 723-730

Spandidos Publications

Access to resources Recommend Favorite

Role of Non-Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

By Tummala Mohan K. Edelman Martin J.

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 245-257

Adis International

Access to resources Recommend Favorite

Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer

By Miyata Junya Sano Takahiro Bando Hiroyasu

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 11-14

Humana Press, Inc

Access to resources Recommend Favorite